First results of study show potential of automated oculography using a VR Headset as a biomarker.

It's Myasthenia Gravis (MG) Awareness Month - all about raising awareness and promoting further research. While there is no known cure for MG, there are many treatments that can make a difference to the lives of people living with MG. Early and accurate diagnosis and monitoring of the disease is very important.  

At the EUNOS 2024 annual meeting of the European Neuro-Ophthalmology Society, held in Rotterdam in early June, Melina Katsimpoura, an MD student in neurology at St. Josef-Hospital, Ruhr-University Bochum, presented first research results of the severely affected myasthenic patients with machineMD's technology. The automated oculography tests with a VR headset showed that it is possible to visualise different phenomena of oculomotor impairment and to objectify symptoms of musclar fatigue of eye movements.  

PD Dr Anke Salmen, Head of the Outpatient Section of the Department of Neurology at Bochum University Hospital, under whose supervision the study was conducted, explains: “The examination has potential as a biomarker for detecting MG-related impairments and their response to symptomatic or immunotherapeutic interventions.” 


Bildschirmfoto 2024-06-14 um 15.28.15